Abstract
This study described the prevalence and correlates of comorbid moderate–severe depressive symptoms (comorbid depression thereafter) and their association with quality of life (QOL) in schizophrenia patients treated in primary care. 623 schizophrenia patients were enrolled. Patients’ socio-demographic and clinical characteristics including comorbid depression [defined as a total score of 18 or above on the Montgomery–Asberg Depression Rating Scale (MADRS)] were recorded. Depressive symptoms (defined as a total score of 9 or above on the MADRS) were present in 54.1 % of patients, while 17.7 % had comorbid depression. Analysis of covariance revealed that comorbid depression was significantly associated with lower mental QOL. Multiple logistic regression analysis revealed that more severe positive and negative symptoms, anxiety symptoms, use of first-generation antipsychotics and antidepressants, were independently associated with comorbid depression. Given the negative association between comorbid depression and QOL, attempts to address comorbid depression in schizophrenia patients treated in primary care should be made.
References
APA. (1997). Practice Guideline for the Treatment of Patients with Schizophrenia. Washington, DC: American Psychiatric Press.
Baynes, D., Mulholland, C., Cooper, S. J., Montgomery, R. C., MacFlynn, G., Lynch, G., et al. (2000). Depressive symptoms in stable chronic schizophrenia: Prevalence and relationship to psychopathology and treatment. Schizophrenia Research, 45(1–2), 47–56.
Buckley, P. F., Miller, B. J., Lehrer, D. S., & Castle, D. J. (2009). Psychiatric comorbidities and schizophrenia. Schizophrenia Bulletin, 35(2), 383–402.
Chiappelli, J., Kochunov, P., DeRiso, K., Thangavelu, K., Sampath, H., Muellerklein, F., et al. (2014). Testing trait depression as a potential clinical domain in schizophrenia. Schizophrenia Research, 159(1), 243–248.
Conley, R. R. (2009). The burden of depressive symptoms in people with schizophrenia. Psychiatric Clinics of North America, 32(4), 853–861.
Conley, R. R., Ascher-Svanum, H., Zhu, B., Faries, D. E., & Kinon, B. J. (2007). The burden of depressive symptoms in the long-term treatment of patients with schizophrenia. Schizophrenia Research, 90(1–3), 186–197.
Delaney, C., McGrane, J., Cummings, E., Morris, D. W., Tropea, D., Gill, M., et al. (2012). Preserved cognitive function is associated with suicidal ideation and single suicide attempts in schizophrenia. Schizophrenia Research, 140(1–3), 232–236.
Gaur, V., Jagawat, T., Dhanda, A., Parakh, P., Raikhy, S., Patel, A., et al. (2014). Depression in schizophrenia: Correlation with psychopathology and level of functioning. Delhi Psychiatry Journal, 17, 83–88.
Gozdzik-Zelazny, A., Borecki, L., & Pokorski, M. (2011). Depressive symptoms in schizophrenic patients. European Journal of Medical Research, 16(12), 549–552.
Hafner, H., Maurer, K., Trendler, G., an der Heiden, W., Schmidt, M. & Konnecke, R. (2005). Schizophrenia and depression: Challenging the paradigm of two separate diseases––a controlled study of schizophrenia, depression and healthy controls. Schizophrenia Research, 77(1), 11–24.
Himelhoch, S., Slade, E., Kreyenbuhl, J., Medoff, D., Brown, C., & Dixon, L. (2012). Antidepressant prescribing patterns among VA patients with schizophrenia. Schizophrenia Research. doi:10.1016/j.schres.2012.1001.1008.
Huppert, J. D., Weiss, K. A., Lim, R., Pratt, S., & Smith, T. E. (2001). Quality of life in schizophrenia: Contributions of anxiety and depression. Schizophrenia Research, 51(2–3), 171–180.
Kane, J. M., Aguglia, E., Altamura, A. C., Ayuso Gutierrez, J. L., Brunello, N., Fleischhacker, W. W., et al. (1998). Guidelines for depot antipsychotic treatment in schizophrenia. European Neuropsychopharmacology consensus conference in Siena, Italy. European Neuropsychopharmacology, 8(1), 55–66.
Kinon, B. J., Lipkovich, I., Edwards, S. B., Adams, D. H., Ascher-Svanum, H., & Siris, S. G. (2006). A 24-week randomized study of olanzapine versus ziprasidone in the treatment of schizophrenia or schizoaffective disorder in patients with prominent depressive symptoms. Journal of Clinical Psychopharmacology, 26(2), 157–162.
Kleinman, A. (2004). Culture and depression. New England Journal of Medicine, 351(10), 951–953.
Kulhara, P., Avasthi, A., Chadda, R., Chandiramani, K., Mattoo, S. K., Kota, S. K., et al. (1989). Negative and depressive symptoms in schizophrenia. British Journal of Psychiatry, 154, 207–211.
Kuo, P. J., Ma, H. I., Kuo, C. C., Huang, W. C., & Chung, M. S. (2009). Factor analysis of the schizophrenia quality of life scale revision 4 (SQLS-R4) Chinese version and related factors. International Journal of Psychiatry in Clinical Practice, 13(4), 278–284.
Lam, C. L., Tse, E. Y., & Gandek, B. (2005). Is the standard SF-12 health survey valid and equivalent for a Chinese population? Quality of Life Research, 14(2), 539–547.
Lancon, C., Auquier, P., Reine, G., Bernard, D., & Addington, D. (2001). Relationships between depression and psychotic symptoms of schizophrenia during an acute episode and stable period. Schizophrenia Research, 47(2–3), 135–140.
Lancon, C., Auquier, P., Reine, G., Bernard, D., & Toumi, M. (2000). Study of the concurrent validity of the calgary depression scale for schizophrenics (CDSS). Journal of Affective Disorders, 58(2), 107–115.
Lee, D. T., Kleinman, J., & Kleinman, A. (2007). Rethinking depression: An ethnographic study of the experiences of depression among Chinese. Harvard Review of Psychiatry, 15(1), 1–8.
Liu, J., Xiang, Y.T., Lei, H., Wang, Q., Wang, G., Ungvari, G.S., et al. (2014). Guidance on the conversion of the Chinese versions of the quick inventory of depressive symptomatology-self-report (C-QIDS-SR) and the Montgomery-Asberg Scale (C-MADRS) in Chinese patients with major depression. Journal of Affective Disorders, 152, 530–533.
Liu, L. Q., & Zhou, P. (2009). Depressive symptoms in patients with chronic schizophrenia (in Chinese). Journal of Clinical Psychiatry, 19, 34–36.
Ma, X., Xiang, Y. T., Cai, Z. J., Li, S. R., Xiang, Y. Q., Guo, H. L., et al. (2009). Lifetime prevalence of suicidal ideation, suicide plans and attempts in rural and urban regions of Beijing, China. Australian and New Zealand Journal of Psychiatry, 43(2), 158–166.
Maier, W., Lichtermann, D., Franke, P., Heun, R., Falkai, P., & Rietschel, M. (2002). The dichotomy of schizophrenia and affective disorders in extended pedigrees. Schizophrenia Research, 57(2–3), 259–266.
Majadas, S., Olivares, J., Galan, J., & Diez, T. (2012). Prevalence of depression and its relationship with other clinical characteristics in a sample of patients with stable schizophrenia. Comprehensive Psychiatry, 53(2), 145–151.
Maust, D.T., Kim, H.M., Seyfried, L.S., Chiang, C., Kavanagh, J., Schneider, L.S., et al. (2015). Antipsychotics, other psychotropics, and the risk of death in patients with dementia: Number needed to harm. JAMA Psychiatry. doi:10.1001/jamapsychiatry.2014, 3018.
McEvoy, J. P., Aland, J. Jr., Wilson, W. H., Guy, W., & Hawkins, L. (1981). Measuring chronic schizophrenic patients attitudes toward their illness and treatment. Hospital and Community Psychiatry, 32(12), 856–858.
Miles, C. P. (1977). Conditions predisposing to suicide: A review. Journal of Nervous and Mental Disease, 164(4), 231–246.
Montgomery, S. A., & Asberg, M. (1979). A new depression scale designed to be sensitive to change. British Journal of Psychiatry, 134, 382–389.
Muller, M. J., Muller, K. M., & Fellgiebel, A. (2006). Detection of depression in acute schizophrenia: Sensitivity and specificity of 2 standard observer rating scales. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie, 51(6), 387–392.
Murali, T., & Ravi Kumar, S. (2008). Symptoms of depression in schizophrenia. Indian Journal of Medical Research, 127(6), 516–518.
Ng, C. H., Ma, H., Yu, X., Chiu, H., Fraser, J., Chan, S., et al. (2009). China-Australia-Hong Kong tripartite community mental health training program. Asia-Pacific Psychiatry, 1, 90–97.
Overall, J. E., & Beller, S. A. (1984). The brief psychiatric rating scale (BPRS) in geropsychiatric research: I. Factor structure on an inpatient unit. Journal of Gerontology, 39(2), 187–193.
Palmer, B. A., Pankratz, V. S., & Bostwick, J. M. (2005). The lifetime risk of suicide in schizophrenia: A reexamination. Archives of General Psychiatry, 62(3), 247–253.
Prosser, E. S., Csernansky, J. G., Kaplan, J., Thiemann, S., Becker, T. J., & Hollister, L. E. (1987). Depression, parkinsonian symptoms, and negative symptoms in schizophrenics treated with neuroleptics. Journal of Nervous and Mental Disease, 175(2), 100–105.
Romm, K. L., Rossberg, J. I., Berg, A. O., Barrett, E. A., Faerden, A., Agartz, I., et al. (2010). Depression and depressive symptoms in first episode psychosis. Journal of Nervous and Mental Disease, 198(1), 67–71.
Roy, A. (1986). Suicide in schizophrenia. In A. Roy (Ed.), Suicide (pp. 97–112). Baltimore: Williams & Wilkins.
Scholes, B., & Martin, C. R. (2013). Measuring depression in schizophrenia with questionnaires. Journal of Psychiatric and Mental Health Nursing, 20(1), 17–22.
Schotte, C. K., Van Den Bossche, B., De Doncker, D., Claes, S., & Cosyns, P. (2006). A biopsychosocial model as a guide for psychoeducation and treatment of depression. Depression and Anxiety, 23(5), 312–324.
Simpson, G. M., & Angus, J. W. (1970). A rating scale for extrapyramidal side effects. Acta Psychiatrica Scandinavica. Supplementum, 212, 11–19.
Siris, S. G. (2000). Depression in schizophrenia: Perspective in the era of “Atypical” antipsychotic agents. American Journal of Psychiatry, 157(9), 1379–1389.
Siris, S. G., & Bench, C. (2003). Depression and schizophrenia. In S. R. Hirsch & D. R. Weinberger (Eds.), Schizophrenia (2nd edn., pp. 142–167). Oxford: Blackwell Publishing.
Staring, A. B., Van der Gaag, M., Van den Berge, M., Duivenvoorden, H. J., & Mulder, C. L. (2009). Stigma moderates the associations of insight with depressed mood, low self-esteem, and low quality of life in patients with schizophrenia spectrum disorders. Schizophrenia Research, 115(2–3), 363–369.
Taylor, D., Paton, C., & Kerwin, R. (2003). The Maudsley Prescribing Guidelines. London: Martin Dunitz.
van Os, J., Verdoux, H., Maurice-Tison, S., Gay, B., Liraud, F., Salamon, R., et al. (1999). Self-reported psychosis-like symptoms and the continuum of psychosis. Social Psychiatry and Psychiatric Epidemiology, 34(9), 459–463.
Wegener, S., Redoblado-Hodge, M. A., Lucas, S., Fitzgerald, D., Harris, A., & Brennan, J. (2005). Relative contributions of psychiatric symptoms and neuropsychological functioning to quality of life in first-episode psychosis. Australian and New Zealand Journal of Psychiatry, 39(6), 487–492.
Woods, S. W. (2003). Chlorpromazine equivalent doses for the newer atypical antipsychotics. Journal of Clinical Psychiatry, 64(6), 663–667.
World Health Organisation. (1973). The International Pilot Study of Schizophrenia. Geneva: World Health Organisation.
Xiang, Y. T., Chiu, H. F., & Ungvari, G. S. (2010). Quality of life and mental health in Chinese culture. Current Opinion in Psychiatry, 23(1), 43–47.
Zhang, M. Y., Zhou, T. J., Tang, S. H., Chi, Y. F., Xia, M. L., & Wang, Z. Y. (1983). The application of the Chinese version of the Brief Psychiatric Rating Scale (BPRS) (in Chinese). Chinese Journal of Nervous and Mental Diseases, 9, 76–80.
Zhong, B. L., Wang, Y., Chen, H. H., & Wang, X. H. (2011). Reliability, validity and sensitivity of Montgomery–Åsberg Depression Rating Scale for patients with current major depressive disorder (in Chinese). Chinese Journal of Behavioural Medicine and Brain Sciences, 20, 85–87.
Zisook, S., McAdams, L. A., Kuck, J., Harris, M. J., Bailey, A., Patterson, T. L., et al. (1999). Depressive symptoms in schizophrenia. American Journal of Psychiatry, 156(11), 1736–1743.
Zisook, S., Montross, L., Kasckow, J., Mohamed, S., Palmer, B. W., Patterson, T. L., et al. (2007). Subsyndromal depressive symptoms in middle-aged and older persons with schizophrenia. American Journal of Geriatric Psychiatry, 15(12), 1005–1014.
Acknowledgments
The study was supported by the Medical Science and Technology Research Foundation of Guangdong Province (Grant Number: A2014011; C2014016) and the Start-up Research Grant (SRG2014-00019-FHS) and Multi-Year Research Grant (MYRG2015-00230-FHS) from University of Macau. The authors thank all the clinicians for their contribution to this study.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflicts of Interest
The authors had no conflicts of interest in conducting this study or preparing the manuscript.
Additional information
Cai-Lan Hou, Xin-Rong Ma, Mei-Ying Cai and Yan Li have equally contributed to this article.
Rights and permissions
About this article
Cite this article
Hou, CL., Ma, XR., Cai, MY. et al. Comorbid Moderate–Severe Depressive Symptoms and their Association with Quality of Life in Chinese Patients with Schizophrenia Treated in Primary Care. Community Ment Health J 52, 921–926 (2016). https://doi.org/10.1007/s10597-016-0023-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10597-016-0023-5